2004
DOI: 10.1002/jgm.644
|View full text |Cite
|
Sign up to set email alerts
|

Reversal of the silencing of tetracycline‐controlled genes requires the coordinate action of distinctly acting transcription factors

Abstract: Reversal of the silencing of a tetracycline-regulated minimal promoter requires a chromatin-remodeling activity for subsequent promoter activation by the Tet-VP16 fusion protein. Thus, distinct regulatory elements may be combined to obtain long-term regulation and persistent expression of exogenous genes in eukaryotic cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
33
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 29 publications
(35 citation statements)
references
References 56 publications
2
33
0
Order By: Relevance
“…Moreover, mutations of the TRD domain that inhibit H3 interaction correspondingly decrease the ability of CTF-1 to achieve chromatin opening in mammalian cells (58). Irrespective of the precise molecular mechanism involved, these data give new insight into how the anti-silencing and boundary activities of CTF-1 may participate to its transcriptional activation function.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…Moreover, mutations of the TRD domain that inhibit H3 interaction correspondingly decrease the ability of CTF-1 to achieve chromatin opening in mammalian cells (58). Irrespective of the precise molecular mechanism involved, these data give new insight into how the anti-silencing and boundary activities of CTF-1 may participate to its transcriptional activation function.…”
Section: Discussionmentioning
confidence: 91%
“…Alternatively, a variety of transcription activators have been further shown to alter chromatin structure through the recruitment of chromatin remodeling/modifying complexes (56,57). CTF-1 rather possesses a histone binding activity, which has been implicated in CTF-1 anti-silencing activity in mammalian cells (58). The GAL4 fusion proteins studied here support this conclusion, as the histone H3 binding activities of mutant proteins correlate well with transcriptional activation in a chromatin context, as illustrated by the boundary effect, but not with the transcriptional activation potential detected in the absence of native chromatin structure in transient assays.…”
Section: Discussionmentioning
confidence: 99%
“…This observation is consistent with previous studies where CTF/NF1 proteins act as barrier elements that block the propagation of silent chromatin structures, and thus protect transgenes from silencing effects mediated by repressive chromatin structures. 31,32,43 Hence, CTF/NF1 binding sites act both as enhancer-blockers and as barrier insulator elements. Maintenance of a euchromatic status of the provirus should favor the production of retroviral vectors.…”
Section: Discussionmentioning
confidence: 99%
“…30 The CAAT box-binding transcription factor/nuclear factor-1 (NF1, also called CTF/NF1) consists of a family of widely expressed transcription factors that possess a barrier function. 31,32 This family comprises NF1-A, NF1-B, NF1-C and NF1-X subtypes that share the same DNA-binding domain. 33,34 Of note, the NF1-C regulatory domain prevents the propagation of repressive chromatin structures that stem from the telomere, and thereby prevent transgene silencing at mammalian and yeast cells telomeres.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation